Barbara Klencke

2019

In 2019, Barbara Klencke earned a total compensation of $971.4K as Chief Development Officer at ProNAi Therapeutics, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$184,737
Option Awards$297,710
Salary$486,150
Other$2,800
Total$971,397

Klencke received $486.2K in salary, accounting for 50% of the total pay in 2019.

Klencke also received $184.7K in non-equity incentive plan, $297.7K in option awards and $2.8K in other compensation.

Rankings

In 2019, Barbara Klencke's compensation ranked 9,399th out of 13,971 executives tracked by ExecPay. In other words, Klencke earned more than 32.7% of executives.

ClassificationRankingPercentile
All
9,399
out of 13,971
33rd
Division
Manufacturing
3,772
out of 5,701
34th
Major group
Chemicals And Allied Products
1,432
out of 2,200
35th
Industry group
Drugs
1,221
out of 1,886
35th
Industry
Pharmaceutical Preparations
908
out of 1,398
35th
Source: SEC filing on April 24, 2020.

Klencke's colleagues

We found two more compensation records of executives who worked with Barbara Klencke at ProNAi Therapeutics in 2019.

2019

Nick Glover

ProNAi Therapeutics

Chief Executive Officer

2019

Mark Kowalski

ProNAi Therapeutics

Chief Medical Officer

News

You may also like